Deprenyl (phenyl-isopropyl-methyl-propargylamine, also known as Selegiline) is a selective monoamine oxidase-B (MAO-B) inhibitor used clinically in the treatment of PD [28]. The gene discussed is MAOB; the disease is Parkinson disease.